Gender difference in the development of steroid-induced osteonecrosis in rabbits

Rheumatology

Volumn 49, Issue 6, 2010, Pages 1128-1132

  Ikemura, Satoshi ^a   Yamamoto, Takuaki ^a   Nishida, Kenjiro ^a   Motomura, Goro ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Animal model; Corticosteroid; Gender; Osteonecrosis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROID;

ADIPOCYTE; ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD EXAMINATION; BONE MARROW CELL; BONE NECROSIS; CONTROLLED STUDY; EXPERIMENTAL RABBIT; FEMALE; FEMUR; HISTOPATHOLOGY; HUMERUS; INCIDENCE; MALE; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW CELLS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, ANIMAL; OSTEONECROSIS; RABBITS; SEX FACTORS; STEROIDS; YOUNG ADULT;

EID: 77953491813     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq044     Document Type: Article

References (20)

1. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32:94-124.
2. Ortiguera CJ, Pulliam IT, Cabanela ME. Total hip arthro-plasty for osteonecrosis: matched-pair analysis of 188 hips with long-term follow-up. J Arthroplasty 1999;14:21-8.
3. Jones JP Jr. Intravascular coagulation and osteonecrosis. Clin Orthop 1992;277:41-53.
4. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 1997;40:2055-64.
5. Miyanishi K, Yamamoto T, Irisa T et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroidtreated rabbits with osteonecrosis. Bone 2002;30:185-90.
6. Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S. Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 2004;9:509-15.
7. Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 2004;50: 3387-91.
8. Miyanishi K, Yamamoto T, Irisa T et al. A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits. Rheumatology 2001;40: 196-201.
9. Oinuma K, Harada Y, Nawata Y et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis 2001;60:1145-8.
10. Nagasawa K, Tada Y, Koarada S et al. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 2005;14:385-90.
11. Jaffe WL, Epstein M, Heyman N, Mankin HJ. The effect of cortisone on femoral and humeral heads in rabbits. An experimental study. Clin Orthop 1972;82:221-8.
12. Wang GJ, Moga DB, Richemer WG, Sweet DE, Reger SI, Thompson RC. Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop 1978;130: 81-5.
13. Cui Q, Wang GJ, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am 1997;79:1054-63.
14. Nishida K, Yamamoto Y, Motomura G, Jingushi S, Iwamoto Y. Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study. Clin Orthop 2008;466:1054-8.
15. American Heart Association Writing Group. Heart Disease and Stroke Statistics-2006 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113: e85-151.
16. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Gender differences in atherosclerosis: possible role of nitric oxide. J Cardiovasc Pharmacol 1995;26:792-802.
17. Lobo J, Jack DB, Kendall MJ. The intraand inter-subject variability of nifedipine pharmacokinetics in young volunteers. Eur J Clin Pharmacol 1986;30:57-60.
18. Zhu B, Liu ZQ, Chen GL et al. The distribution and gender difference of CYP3A activity in Chinese subjects. Br J Clin Pharmacol 2003;55:264-9.
19. Masada T, Iwakiri K, Oda Y et al. Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J Orthop Res 2008;26:91-5.
20. Miyanishi K, Yamamoto T, Irisa T, Noguchi Y, Sugioka Y, Iwamoto Y. Increased level of apolipoprotein B/apolipo-protein A1 ratio as a potential risk for osteonecrosis. Ann Rheum Dis 1999;58:514-6.